Overview

A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma

Status:
Terminated
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether immune therapy with anti-CTLA4 antibody is effective in people with advanced synovial sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Ludwig Institute for Cancer Research
Collaborator:
Medarex
Treatments:
Antibodies
Antibodies, Monoclonal
Immunoglobulins